Company Overview

IGC PHARMA, INC.

IGC
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
1M
2024 FY
Net Income
-7M
2024 FY
Shares Outstanding
77M
2024 FY
EPS
-0.09USD
2024 FY
Company Information
SIC Code
2834
CIK Code
1326205
Exchange
NYSE
Location
US